Ads
related to: revlimid drug- Treatment Option
Visit The Physician Website To
Learn More About This Treatment.
- Mechanism Of Action
Learn How To Treat Patients
With Ph+ CML-CP Today.
- $0 Co-Pay Information
Patients With Private Insurance
Could Save On Their Prescription.
- Safety Profile
Physicians, See Important Safety
Information About This Treatment.
- Efficacy Information
Physicians, See How This Treatment
May Help Your Patients Today.
- View Patient Profiles
Patients Experience Treatment
Intolerance & Suboptimal Responses
- Treatment Option
Search results
Bristol Myers' Revlimid Takes A 32% Hit As Generics Keep Coming
Investor's Business Daily· 1 year agoBristol Myers Squibb's Revlimid took fewer than expected generic hits in the fourth quarter,...
Revlimid Generic Competition, Forex Impacts Bristol Myers' Q3 Sales; Reaffirms FY22 Guidance
Benzinga via Yahoo Finance· 2 years agoBristol Myers Squibb & Co (NYSE: BMY) said that its Q3 sales of $11.22 billion fell 3% Y/Y as...
Bristol-Myers (BMY) Q2 Earnings, Sales Miss, '23 View Lowered
Zacks via Yahoo Finance· 10 months agoBristol-Myers' (BMY) second-quarter 2023 earnings and sales miss estimates due to generic erosion...
Bristol Myers profit beats estimates on resilient Revlimid sales
Reuters via Yahoo Finance· 2 years ago(Reuters) -Bristol Myers Squibb Co on Wednesday reported bigger second-quarter profit than expected...
Bristol Myers (BMY) Loses 10.5% Year-to-Date: What Lies Ahead?
Zacks via Yahoo Finance· 1 year agoBristol-Myers' (BMY) top drugs, Revlimid and Eliquis, face challenges. It remains to be seen if the...
Bristol Myers Squibb Proved in Q3 Why Its Diverse Portfolio Makes It a Solid Investment
Motley Fool· 7 months agoBristol Myers Squibb (NYSE: BMY) is one of the largest healthcare companies in the world. The...
Bristol-Myers (BMY) Q3 Earnings Beat, Sales Decline Y/Y
Zacks via Yahoo Finance· 2 years agoBristol-Myers Squibb Company BMY reported decent results for the third quarter of 2022. The company...
Bristol Myers' profit beats on better-than-feared Revlimid sales
Reuters via Yahoo Finance· 1 year ago(Reuters) -Bristol Myers Squibb Co on Thursday reported quarterly earnings that beat analysts'...
Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
Time via Yahoo News· 1 year agoProtect Our Care sponsors Lite-Brite demonstration outside of PhRMA’s headquarters calling for an...
How to choose a Medicare Part D prescription drug plan
Fortune via Yahoo Finance· 9 months agoSelecting a Part D prescription drug plan is one of the hardest Medicare decisions because there are...
Ads
related to: revlimid drug